Loading…
The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors
The dopamine D2 and D3 receptors (D2R and D3R) are important targets for antipsychotics and for the treatment of drug abuse. SB269652, a bitopic ligand that simultaneously binds both the orthosteric binding site (OBS) and a secondary binding pocket (SBP) in both D2R and D3R, was found to be a negati...
Saved in:
Published in: | PLoS computational biology 2018-01, Vol.14 (1), p.e1005948-e1005948 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3 |
container_end_page | e1005948 |
container_issue | 1 |
container_start_page | e1005948 |
container_title | PLoS computational biology |
container_volume | 14 |
creator | Verma, Ravi Kumar Abramyan, Ara M Michino, Mayako Free, R Benjamin Sibley, David R Javitch, Jonathan A Lane, J Robert Shi, Lei |
description | The dopamine D2 and D3 receptors (D2R and D3R) are important targets for antipsychotics and for the treatment of drug abuse. SB269652, a bitopic ligand that simultaneously binds both the orthosteric binding site (OBS) and a secondary binding pocket (SBP) in both D2R and D3R, was found to be a negative allosteric modulator. Previous studies identified Glu2.65 in the SBP to be a key determinant of both the affinity of SB269652 and the magnitude of its cooperativity with orthosteric ligands, as the E2.65A mutation decreased both of these parameters. However, the proposed hydrogen bond (H-bond) between Glu2.65 and the indole moiety of SB269652 is not a strong interaction, and a structure activity relationship study of SB269652 indicates that this H-bond may not be the only element that determines its allosteric properties. To understand the structural basis of the observed phenotype of E2.65A, we carried out molecular dynamics simulations with a cumulative length of ~77 μs of D2R and D3R wild-type and their E2.65A mutants bound to SB269652. In combination with Markov state model analysis and by characterizing the equilibria of ligand binding modes in different conditions, we found that in both D2R and D3R, whereas the tetrahydroisoquinoline moiety of SB269652 is stably bound in the OBS, the indole-2-carboxamide moiety is dynamic and only intermittently forms H-bonds with Glu2.65. Our results also indicate that the E2.65A mutation significantly affects the overall shape and size of the SBP, as well as the conformation of the N terminus. Thus, our findings suggest that the key role of Glu2.65 in mediating the allosteric properties of SB269652 extends beyond a direct interaction with SB269652, and provide structural insights for rational design of SB269652 derivatives that may retain its allosteric properties. |
doi_str_mv | 10.1371/journal.pcbi.1005948 |
format | article |
fullrecord | <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_2002623121</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c32595f0cebf4f86b145258df520dd63</doaj_id><sourcerecordid>1989578006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3</originalsourceid><addsrcrecordid>eNptkktv1DAUhSMEog_4BwgssWEzgx-xE2-QSlugUiUWlLXlx_XUo4wd7KRS_z1uJ61axMpX198519c6TfOO4DVhHfm8TXOOeliP1oQ1wZjLtn_RHBLO2apjvH_5pD5ojkrZYlxLKV43B1Qy1sleHDbm6hrQOV0LfoJ286SnkCJyoeR5nApyt1HvgkUmRBfiBo2pQEHJo19fqZCCU6QnNFUHl8YKRkBntRUdOmMog4VxSrm8aV55PRR4u5zHze9v51enP1aXP79fnJ5crmxdp18JgZkz1mtuO6AAwB1vjew805JrA4T4imnLCBaOGOyJh653pOIeWmrYcfNh7zsOqajle4qiGFNBGaGkEhd7wiW9VWMOO51vVdJB3TdS3iidp2AHUJZRLrnHFoxvfS8MaTnlvfOcYucEq15flmmz2YGzEKesh2emz29iuFabdKN41wtGZDX4tBjk9GeGMqldKBaGQUdIc1FE9rKyGIuKfvwH_f927Z6yOZWSwT8-hmB1F5kHlbqLjFoiU2Xvny7yKHrICPsLZ8u9gg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2002623121</pqid></control><display><type>article</type><title>The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Verma, Ravi Kumar ; Abramyan, Ara M ; Michino, Mayako ; Free, R Benjamin ; Sibley, David R ; Javitch, Jonathan A ; Lane, J Robert ; Shi, Lei</creator><contributor>Jacobs, Donald</contributor><creatorcontrib>Verma, Ravi Kumar ; Abramyan, Ara M ; Michino, Mayako ; Free, R Benjamin ; Sibley, David R ; Javitch, Jonathan A ; Lane, J Robert ; Shi, Lei ; Jacobs, Donald</creatorcontrib><description>The dopamine D2 and D3 receptors (D2R and D3R) are important targets for antipsychotics and for the treatment of drug abuse. SB269652, a bitopic ligand that simultaneously binds both the orthosteric binding site (OBS) and a secondary binding pocket (SBP) in both D2R and D3R, was found to be a negative allosteric modulator. Previous studies identified Glu2.65 in the SBP to be a key determinant of both the affinity of SB269652 and the magnitude of its cooperativity with orthosteric ligands, as the E2.65A mutation decreased both of these parameters. However, the proposed hydrogen bond (H-bond) between Glu2.65 and the indole moiety of SB269652 is not a strong interaction, and a structure activity relationship study of SB269652 indicates that this H-bond may not be the only element that determines its allosteric properties. To understand the structural basis of the observed phenotype of E2.65A, we carried out molecular dynamics simulations with a cumulative length of ~77 μs of D2R and D3R wild-type and their E2.65A mutants bound to SB269652. In combination with Markov state model analysis and by characterizing the equilibria of ligand binding modes in different conditions, we found that in both D2R and D3R, whereas the tetrahydroisoquinoline moiety of SB269652 is stably bound in the OBS, the indole-2-carboxamide moiety is dynamic and only intermittently forms H-bonds with Glu2.65. Our results also indicate that the E2.65A mutation significantly affects the overall shape and size of the SBP, as well as the conformation of the N terminus. Thus, our findings suggest that the key role of Glu2.65 in mediating the allosteric properties of SB269652 extends beyond a direct interaction with SB269652, and provide structural insights for rational design of SB269652 derivatives that may retain its allosteric properties.</description><identifier>ISSN: 1553-7358</identifier><identifier>ISSN: 1553-734X</identifier><identifier>EISSN: 1553-7358</identifier><identifier>DOI: 10.1371/journal.pcbi.1005948</identifier><identifier>PMID: 29337986</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Allosteric properties ; Allosteric Regulation ; Allosteric Site ; Antipsychotics ; Bayes Theorem ; Binding sites ; Biology and Life Sciences ; Biophysics ; Chemical bonds ; Cluster Analysis ; Computational chemistry ; Computer Simulation ; Conformation ; Dopamine ; Dopamine D2 receptors ; Dopamine D3 receptors ; Drug abuse ; Humans ; Hydrogen Bonding ; Hydrogen bonds ; Indoles ; Indoles - chemistry ; Isoquinolines - chemistry ; Ligands ; Markov Chains ; Medicine and Health Sciences ; Molecular dynamics ; Molecular Dynamics Simulation ; Mutants ; Mutation ; Phenotype ; Phenotypes ; Physical Sciences ; Prescription drugs ; Properties (attributes) ; Protein Binding ; Protein Domains ; Protein Structure, Secondary ; Proteins ; Receptors ; Receptors, Dopamine D2 - chemistry ; Receptors, Dopamine D2 - genetics ; Receptors, Dopamine D3 - chemistry ; Receptors, Dopamine D3 - genetics ; Research and Analysis Methods ; Strong interactions (field theory) ; Structure-Activity Relationship ; Tetrahydroisoquinoline</subject><ispartof>PLoS computational biology, 2018-01, Vol.14 (1), p.e1005948-e1005948</ispartof><rights>2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors. PLoS Comput Biol 14(1): e1005948. https://doi.org/10.1371/journal.pcbi.1005948</rights><rights>2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors. PLoS Comput Biol 14(1): e1005948. https://doi.org/10.1371/journal.pcbi.1005948</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3</citedby><cites>FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3</cites><orcidid>0000-0002-4137-096X ; 0000-0002-7361-7875 ; 0000-0002-2428-0487</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2002623121/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2002623121?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29337986$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Jacobs, Donald</contributor><creatorcontrib>Verma, Ravi Kumar</creatorcontrib><creatorcontrib>Abramyan, Ara M</creatorcontrib><creatorcontrib>Michino, Mayako</creatorcontrib><creatorcontrib>Free, R Benjamin</creatorcontrib><creatorcontrib>Sibley, David R</creatorcontrib><creatorcontrib>Javitch, Jonathan A</creatorcontrib><creatorcontrib>Lane, J Robert</creatorcontrib><creatorcontrib>Shi, Lei</creatorcontrib><title>The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors</title><title>PLoS computational biology</title><addtitle>PLoS Comput Biol</addtitle><description>The dopamine D2 and D3 receptors (D2R and D3R) are important targets for antipsychotics and for the treatment of drug abuse. SB269652, a bitopic ligand that simultaneously binds both the orthosteric binding site (OBS) and a secondary binding pocket (SBP) in both D2R and D3R, was found to be a negative allosteric modulator. Previous studies identified Glu2.65 in the SBP to be a key determinant of both the affinity of SB269652 and the magnitude of its cooperativity with orthosteric ligands, as the E2.65A mutation decreased both of these parameters. However, the proposed hydrogen bond (H-bond) between Glu2.65 and the indole moiety of SB269652 is not a strong interaction, and a structure activity relationship study of SB269652 indicates that this H-bond may not be the only element that determines its allosteric properties. To understand the structural basis of the observed phenotype of E2.65A, we carried out molecular dynamics simulations with a cumulative length of ~77 μs of D2R and D3R wild-type and their E2.65A mutants bound to SB269652. In combination with Markov state model analysis and by characterizing the equilibria of ligand binding modes in different conditions, we found that in both D2R and D3R, whereas the tetrahydroisoquinoline moiety of SB269652 is stably bound in the OBS, the indole-2-carboxamide moiety is dynamic and only intermittently forms H-bonds with Glu2.65. Our results also indicate that the E2.65A mutation significantly affects the overall shape and size of the SBP, as well as the conformation of the N terminus. Thus, our findings suggest that the key role of Glu2.65 in mediating the allosteric properties of SB269652 extends beyond a direct interaction with SB269652, and provide structural insights for rational design of SB269652 derivatives that may retain its allosteric properties.</description><subject>Allosteric properties</subject><subject>Allosteric Regulation</subject><subject>Allosteric Site</subject><subject>Antipsychotics</subject><subject>Bayes Theorem</subject><subject>Binding sites</subject><subject>Biology and Life Sciences</subject><subject>Biophysics</subject><subject>Chemical bonds</subject><subject>Cluster Analysis</subject><subject>Computational chemistry</subject><subject>Computer Simulation</subject><subject>Conformation</subject><subject>Dopamine</subject><subject>Dopamine D2 receptors</subject><subject>Dopamine D3 receptors</subject><subject>Drug abuse</subject><subject>Humans</subject><subject>Hydrogen Bonding</subject><subject>Hydrogen bonds</subject><subject>Indoles</subject><subject>Indoles - chemistry</subject><subject>Isoquinolines - chemistry</subject><subject>Ligands</subject><subject>Markov Chains</subject><subject>Medicine and Health Sciences</subject><subject>Molecular dynamics</subject><subject>Molecular Dynamics Simulation</subject><subject>Mutants</subject><subject>Mutation</subject><subject>Phenotype</subject><subject>Phenotypes</subject><subject>Physical Sciences</subject><subject>Prescription drugs</subject><subject>Properties (attributes)</subject><subject>Protein Binding</subject><subject>Protein Domains</subject><subject>Protein Structure, Secondary</subject><subject>Proteins</subject><subject>Receptors</subject><subject>Receptors, Dopamine D2 - chemistry</subject><subject>Receptors, Dopamine D2 - genetics</subject><subject>Receptors, Dopamine D3 - chemistry</subject><subject>Receptors, Dopamine D3 - genetics</subject><subject>Research and Analysis Methods</subject><subject>Strong interactions (field theory)</subject><subject>Structure-Activity Relationship</subject><subject>Tetrahydroisoquinoline</subject><issn>1553-7358</issn><issn>1553-734X</issn><issn>1553-7358</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkktv1DAUhSMEog_4BwgssWEzgx-xE2-QSlugUiUWlLXlx_XUo4wd7KRS_z1uJ61axMpX198519c6TfOO4DVhHfm8TXOOeliP1oQ1wZjLtn_RHBLO2apjvH_5pD5ojkrZYlxLKV43B1Qy1sleHDbm6hrQOV0LfoJ286SnkCJyoeR5nApyt1HvgkUmRBfiBo2pQEHJo19fqZCCU6QnNFUHl8YKRkBntRUdOmMog4VxSrm8aV55PRR4u5zHze9v51enP1aXP79fnJ5crmxdp18JgZkz1mtuO6AAwB1vjew805JrA4T4imnLCBaOGOyJh653pOIeWmrYcfNh7zsOqajle4qiGFNBGaGkEhd7wiW9VWMOO51vVdJB3TdS3iidp2AHUJZRLrnHFoxvfS8MaTnlvfOcYucEq15flmmz2YGzEKesh2emz29iuFabdKN41wtGZDX4tBjk9GeGMqldKBaGQUdIc1FE9rKyGIuKfvwH_f927Z6yOZWSwT8-hmB1F5kHlbqLjFoiU2Xvny7yKHrICPsLZ8u9gg</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Verma, Ravi Kumar</creator><creator>Abramyan, Ara M</creator><creator>Michino, Mayako</creator><creator>Free, R Benjamin</creator><creator>Sibley, David R</creator><creator>Javitch, Jonathan A</creator><creator>Lane, J Robert</creator><creator>Shi, Lei</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AL</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K7-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0N</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4137-096X</orcidid><orcidid>https://orcid.org/0000-0002-7361-7875</orcidid><orcidid>https://orcid.org/0000-0002-2428-0487</orcidid></search><sort><creationdate>201801</creationdate><title>The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors</title><author>Verma, Ravi Kumar ; Abramyan, Ara M ; Michino, Mayako ; Free, R Benjamin ; Sibley, David R ; Javitch, Jonathan A ; Lane, J Robert ; Shi, Lei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Allosteric properties</topic><topic>Allosteric Regulation</topic><topic>Allosteric Site</topic><topic>Antipsychotics</topic><topic>Bayes Theorem</topic><topic>Binding sites</topic><topic>Biology and Life Sciences</topic><topic>Biophysics</topic><topic>Chemical bonds</topic><topic>Cluster Analysis</topic><topic>Computational chemistry</topic><topic>Computer Simulation</topic><topic>Conformation</topic><topic>Dopamine</topic><topic>Dopamine D2 receptors</topic><topic>Dopamine D3 receptors</topic><topic>Drug abuse</topic><topic>Humans</topic><topic>Hydrogen Bonding</topic><topic>Hydrogen bonds</topic><topic>Indoles</topic><topic>Indoles - chemistry</topic><topic>Isoquinolines - chemistry</topic><topic>Ligands</topic><topic>Markov Chains</topic><topic>Medicine and Health Sciences</topic><topic>Molecular dynamics</topic><topic>Molecular Dynamics Simulation</topic><topic>Mutants</topic><topic>Mutation</topic><topic>Phenotype</topic><topic>Phenotypes</topic><topic>Physical Sciences</topic><topic>Prescription drugs</topic><topic>Properties (attributes)</topic><topic>Protein Binding</topic><topic>Protein Domains</topic><topic>Protein Structure, Secondary</topic><topic>Proteins</topic><topic>Receptors</topic><topic>Receptors, Dopamine D2 - chemistry</topic><topic>Receptors, Dopamine D2 - genetics</topic><topic>Receptors, Dopamine D3 - chemistry</topic><topic>Receptors, Dopamine D3 - genetics</topic><topic>Research and Analysis Methods</topic><topic>Strong interactions (field theory)</topic><topic>Structure-Activity Relationship</topic><topic>Tetrahydroisoquinoline</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Verma, Ravi Kumar</creatorcontrib><creatorcontrib>Abramyan, Ara M</creatorcontrib><creatorcontrib>Michino, Mayako</creatorcontrib><creatorcontrib>Free, R Benjamin</creatorcontrib><creatorcontrib>Sibley, David R</creatorcontrib><creatorcontrib>Javitch, Jonathan A</creatorcontrib><creatorcontrib>Lane, J Robert</creatorcontrib><creatorcontrib>Shi, Lei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Computing Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>Computer Science Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Computing Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PLoS computational biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Verma, Ravi Kumar</au><au>Abramyan, Ara M</au><au>Michino, Mayako</au><au>Free, R Benjamin</au><au>Sibley, David R</au><au>Javitch, Jonathan A</au><au>Lane, J Robert</au><au>Shi, Lei</au><au>Jacobs, Donald</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors</atitle><jtitle>PLoS computational biology</jtitle><addtitle>PLoS Comput Biol</addtitle><date>2018-01</date><risdate>2018</risdate><volume>14</volume><issue>1</issue><spage>e1005948</spage><epage>e1005948</epage><pages>e1005948-e1005948</pages><issn>1553-7358</issn><issn>1553-734X</issn><eissn>1553-7358</eissn><abstract>The dopamine D2 and D3 receptors (D2R and D3R) are important targets for antipsychotics and for the treatment of drug abuse. SB269652, a bitopic ligand that simultaneously binds both the orthosteric binding site (OBS) and a secondary binding pocket (SBP) in both D2R and D3R, was found to be a negative allosteric modulator. Previous studies identified Glu2.65 in the SBP to be a key determinant of both the affinity of SB269652 and the magnitude of its cooperativity with orthosteric ligands, as the E2.65A mutation decreased both of these parameters. However, the proposed hydrogen bond (H-bond) between Glu2.65 and the indole moiety of SB269652 is not a strong interaction, and a structure activity relationship study of SB269652 indicates that this H-bond may not be the only element that determines its allosteric properties. To understand the structural basis of the observed phenotype of E2.65A, we carried out molecular dynamics simulations with a cumulative length of ~77 μs of D2R and D3R wild-type and their E2.65A mutants bound to SB269652. In combination with Markov state model analysis and by characterizing the equilibria of ligand binding modes in different conditions, we found that in both D2R and D3R, whereas the tetrahydroisoquinoline moiety of SB269652 is stably bound in the OBS, the indole-2-carboxamide moiety is dynamic and only intermittently forms H-bonds with Glu2.65. Our results also indicate that the E2.65A mutation significantly affects the overall shape and size of the SBP, as well as the conformation of the N terminus. Thus, our findings suggest that the key role of Glu2.65 in mediating the allosteric properties of SB269652 extends beyond a direct interaction with SB269652, and provide structural insights for rational design of SB269652 derivatives that may retain its allosteric properties.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>29337986</pmid><doi>10.1371/journal.pcbi.1005948</doi><orcidid>https://orcid.org/0000-0002-4137-096X</orcidid><orcidid>https://orcid.org/0000-0002-7361-7875</orcidid><orcidid>https://orcid.org/0000-0002-2428-0487</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1553-7358 |
ispartof | PLoS computational biology, 2018-01, Vol.14 (1), p.e1005948-e1005948 |
issn | 1553-7358 1553-734X 1553-7358 |
language | eng |
recordid | cdi_plos_journals_2002623121 |
source | Open Access: PubMed Central; Publicly Available Content Database (Proquest) (PQ_SDU_P3) |
subjects | Allosteric properties Allosteric Regulation Allosteric Site Antipsychotics Bayes Theorem Binding sites Biology and Life Sciences Biophysics Chemical bonds Cluster Analysis Computational chemistry Computer Simulation Conformation Dopamine Dopamine D2 receptors Dopamine D3 receptors Drug abuse Humans Hydrogen Bonding Hydrogen bonds Indoles Indoles - chemistry Isoquinolines - chemistry Ligands Markov Chains Medicine and Health Sciences Molecular dynamics Molecular Dynamics Simulation Mutants Mutation Phenotype Phenotypes Physical Sciences Prescription drugs Properties (attributes) Protein Binding Protein Domains Protein Structure, Secondary Proteins Receptors Receptors, Dopamine D2 - chemistry Receptors, Dopamine D2 - genetics Receptors, Dopamine D3 - chemistry Receptors, Dopamine D3 - genetics Research and Analysis Methods Strong interactions (field theory) Structure-Activity Relationship Tetrahydroisoquinoline |
title | The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A45%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20E2.65A%20mutation%20disrupts%20dynamic%20binding%20poses%20of%20SB269652%20at%20the%20dopamine%20D2%20and%20D3%20receptors&rft.jtitle=PLoS%20computational%20biology&rft.au=Verma,%20Ravi%20Kumar&rft.date=2018-01&rft.volume=14&rft.issue=1&rft.spage=e1005948&rft.epage=e1005948&rft.pages=e1005948-e1005948&rft.issn=1553-7358&rft.eissn=1553-7358&rft_id=info:doi/10.1371/journal.pcbi.1005948&rft_dat=%3Cproquest_plos_%3E1989578006%3C/proquest_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3718-6603dbcfa5c7e2eee5d54b97f3a95abe11f718ac3106d1b0f1fe78d15c7fe42b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2002623121&rft_id=info:pmid/29337986&rfr_iscdi=true |